Wesbanco Bank Inc. increased its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 5.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 268,416 shares of the company's stock after acquiring an additional 14,025 shares during the quarter. Procter & Gamble comprises approximately 1.3% of Wesbanco Bank Inc.'s investment portfolio, making the stock its 11th biggest holding. Wesbanco Bank Inc.'s holdings in Procter & Gamble were worth $42,764,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of PG. Nuveen LLC bought a new position in Procter & Gamble during the 1st quarter worth approximately $1,954,941,000. GAMMA Investing LLC boosted its stake in Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Invesco Ltd. boosted its stake in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Procter & Gamble by 15.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after acquiring an additional 2,224,912 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Analyst Ratings Changes
Several research analysts recently weighed in on the stock. BNP Paribas reissued an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI restated an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Barclays set a $164.00 target price on shares of Procter & Gamble and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Wells Fargo & Company dropped their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Finally, UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the stock a "buy" rating in a report on Wednesday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus target price of $175.12.
Read Our Latest Research Report on PG
Insider Buying and Selling at Procter & Gamble
In related news, CFO Andre Schulten sold 11,638 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 40,119 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the transaction, the chief executive officer owned 319,375 shares in the company, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock valued at $18,918,012 in the last 90 days. Company insiders own 0.20% of the company's stock.
Procter & Gamble Price Performance
NYSE PG opened at $158.02 on Friday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a market capitalization of $369.85 billion, a PE ratio of 24.27, a price-to-earnings-growth ratio of 4.19 and a beta of 0.36. The firm's 50 day moving average is $156.21 and its 200-day moving average is $161.84.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period last year, the company earned $1.40 earnings per share. The firm's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's payout ratio is presently 64.98%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report